AI's 'Godfather' Proposes FDA-Style Approval System
AI pioneer Geoffrey Hinton proposes that new AI models should require an FDA-like approval process before public release.
Geoffrey Hinton, widely recognized as the 'Godfather of AI' for his foundational contributions to the field, has advocated for a new regulatory framework for artificial intelligence. Hinton suggests that AI models should undergo an approval process similar to that of pharmaceutical drugs before being made available to the public.
Speaking on the "Smart Girl Dumb Questions" podcast, the Nobel Prize-winning computer scientist called for independent regulatory oversight. He drew parallels to the drug industry, where new medications must pass extensive testing and gain approval from bodies like the Food and Drug Administration (FDA), a process that can cost upwards of $1 billion.
Hinton's proposal emerges amid growing concerns within the technology sector regarding the rapid advancement of AI and its potential implications. Industry insiders have increasingly voiced apprehension about the pace of development and the adequacy of existing safety measures.
Currently, AI companies largely self-regulate, determining product readiness and safety internally. Hinton's initiative aims to establish a more rigorous, external validation process to ensure AI technologies are developed responsibly and safely for societal use.